Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Bluenote, a San Francisco-based startup focused on the biopharma sector, has successfully raised $10 million in funding to enhance its AI-powered platform aimed at streamlining regulatory and compliance processes. The funding round included participation from notable investors such as Lux Capital, Deena Shakir, Elad Gil, and Avichal. Bluenote's technology is designed to eliminate manual bottlenecks in drug development, thereby accelerating the delivery of critical medicines to patients. The company is led by former Color Health employees, Fatima Sabar and Kunal Kothari, who are optimistic about the potential impact of their innovations on the life sciences industry.
Big congrats to @bluenote_ai. @MoxxieVentures is proud to be a part of their journey! https://t.co/nJqLMzXM4S
⚡️ We're thrilled to partner with the team @bluenote_ai to help streamline regulatory & compliance work in the drug industry. This is our second time backing incredible founders @fatimasabar & @kn. We're also honored to join investing legends @deenashakir @eladgil and @avichal! https://t.co/dHw8TDqDFe
Today my company Bluenote @bluenote_ai is announcing our $10M raise from @deenashakir @Lux_Capital, @eladgil, @avichal, @othman, @KatieS, @fidjissimo and leaders in AI & biopharma to transform workflows in life sciences https://t.co/rwBYcGd8PX